Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on April 26, 2023.
July 25, 2023 at 07:51 pm EDT
Share
From July 1, 2023 to July 17, 2023, the company has repurchased 10,872 shares, representing 0.13% for KRW 597.25 million. With this, the company has completed the repurchase of 45,872 shares, representing 0.54% for KRW 2,520.87 million under the buyback announced on April 26, 2023.
Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The Company distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.
DONG-A ST CO., LTD. 
